FDA Approves Health Claim for Resistant Starch and Reduced Diabetes Risk


The U.S. FDA has approved a petition filed by Ingredion Incorporated, Westchester, IL, resulting in a qualified health claim that will enable food manufacturers to communicate the relationship between high-amylose maize resistant starch and a reduced risk of Type 2 diabetes on the packages of conventional foods.

Source: FDA Approves Health Claim for Resistant Starch and Reduced Diabetes Risk

Share:

No Comments Yet.

Leave a Reply

Your email address will not be published.